CABG Medical to Make Webcast Presentation at Roth Capital Partners New York Conference - September 7, 2005
29 August 2005 - 11:30PM
PR Newswire (US)
MINNEAPOLIS, Aug. 29 /PRNewswire-FirstCall/ -- CABG Medical, Inc.
(NASDAQ:CABG) today announced that it will present at the Roth
Capital Partners New York Conference on September 7, 2005 at 9:00
a.m. Eastern Daylight Time. The presentation will include
discussions of our human clinical trials, a strategic overview and
review of historical financial performance. Presenting will be
Manny Villafana, Chairman and Chief Executive Officer, who has
previously introduced innovative cardiac surgery products such as
pacemakers and heart valves throughout the world and founded
companies such as Cardiac Pacemakers, Inc. (now Guidant
Corporation), St. Jude Medical, Inc. and ATS Medical, Inc. (Logo:
http://www.newscom.com/cgi-bin/prnh/20050114/CGF013LOGO )
Attendance at the Roth Capital Partners New York Conference is by
invitation only. A live audio-only webcast of the presentation,
hosted by Roth Capital, will also be broadcast via the Internet.
Those interested in listening to the webcast may access it through
the "investor relations" section of CABG Medical's website
http://www.cabgmedical.com/investorRelations.html or at
http://www.wsw.com/webcast/roth6/cabg . An archived replay of the
presentation will also be available approximately one hour
following the live presentation and will remain accessible for 90
days. About CABG Medical CABG Medical, Inc. is a medical technology
company developing technologies and therapies to improve the
treatment of coronary heart disease by advancing conventional
bypass surgery. We have designed our first product, the Holly
Graft(TM) System, by leveraging our understanding of flow dynamics,
material sciences and drug combinations to create a drug-eluting
graft (DEG) for coronary artery bypass surgery. Safe Harbor This
Press Release contains forward-looking statements that may include
statements regarding intent, belief or current expectations of the
Company and its management. Actual results could differ materially
from those projected in the forward-looking statements as a result
of a number of important factors, including regulatory actions,
competition, and management of growth. For a discussion of these
and other risks and uncertainties that could affect the Company's
activities and results, please refer to the Company's filings with
the Securities and Exchange Commission.
http://www.newscom.com/cgi-bin/prnh/20050114/CGF013LOGO
http://photoarchive.ap.org/ DATASOURCE: CABG Medical, Inc. CONTACT:
Manny Villafana, Chairman & CEO, or John L. Babitt, President,
both of CABG Medical, Inc., +1-763-258-8005, fax +1-763-258-8008
Web site: http://www.cabgmedical.com/
http://www.cabgmedical.com/investorRelations.html
http://www.wsw.com/webcast/roth6/cabg
Copyright
Cabg Medical (NASDAQ:CABG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cabg Medical (NASDAQ:CABG)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Cabg Medical (MM) (NASDAQ): 0 recent articles
More Cabg Medical (MM) News Articles